Start Date
November 30, 2024
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
Deucravacitinib
Deucravacitinib 6 mg orally once daily.
Placebo
Matching placebo orally once daily.
Icahn School of Medicine at Mount Sinai, New York
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Icahn School of Medicine at Mount Sinai
OTHER